Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

TEntrada Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
T

Entrada Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $898K. Net result −$42.76M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $898K. Running result $898K. Revenue: $898K.
  • Cost of revenue: $0. Running result $898K.
  • Gross profit: $898K. Running result $898K.
  • Research and development: −$35.37M. Running result −$34.47M.
  • General and administrative: −$10.49M. Running result −$44.96M.
  • Operating income: −$44.96M. Running result −$44.96M.
  • Other income: $2.24M. Running result −$42.73M.
  • Pre-tax loss: −$42.73M. Running result −$42.73M.
  • Income tax expense: −$35K. Running result −$42.76M.
  • Net loss: −$42.76M. Running result −$42.76M.